A citation-based method for searching scientific literature

Asma Abu-Abed Abdin, Muhammad Hamza, Muhammad S Khan, Awab Ahmed. Case Rep Crit Care 2016
Times Cited: 10







List of co-cited articles
58 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial).
Mohammad Shafi Kuchay, Sonal Krishan, Sunil Kumar Mishra, Khalid Jamal Farooqui, Manish Kumar Singh, Jasjeet Singh Wasir, Beena Bansal, Parjeet Kaur, Ganesh Jevalikar, Harmendeep Kaur Gill,[...]. Diabetes Care 2018
246
10

Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.
Timo Rieg, Takahiro Masuda, Maria Gerasimova, Eric Mayoux, Kenneth Platt, David R Powell, Scott C Thomson, Hermann Koepsell, Volker Vallon. Am J Physiol Renal Physiol 2014
165
10

Ketoacidosis during a low-carbohydrate diet.
Pankaj Shah, William L Isley. N Engl J Med 2006
56
10


Drug-induced hyperglycemia.
B Luna, M N Feinglos. JAMA 2001
111
10

Type 2 diabetes.
Sudesna Chatterjee, Kamlesh Khunti, Melanie J Davies. Lancet 2017
835
10

SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.
Ele Ferrannini, Anna Solini. Nat Rev Endocrinol 2012
273
10

Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.
Yu-Mou Chou, Chen-June Seak, Zhong Ning Leonard Goh, Joanna Chen-Yeen Seak, Chen-Ken Seak, Chih-Chuan Lin. Medicine (Baltimore) 2018
18
10

Interindividual Heterogeneity of SGLT2 Expression and Function in Human Pancreatic Islets.
Chiara Saponaro, Markus Mühlemann, Ana Acosta-Montalvo, Anthony Piron, Valery Gmyr, Nathalie Delalleau, Ericka Moerman, Julien Thévenet, Gianni Pasquetti, Anais Coddeville,[...]. Diabetes 2020
30
10

Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.
Rhonda M Cooper-DeHoff, Sheron Wen, Amber L Beitelshees, Issam Zineh, John G Gums, Stephen T Turner, Yan Gong, Karen Hall, Vishal Parekh, Arlene B Chapman,[...]. Hypertension 2010
38
10

Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition.
Debapriya Basu, Lesley-Ann Huggins, Diego Scerbo, Joseph Obunike, Adam E Mullick, Paul L Rothenberg, Nicholas A Di Prospero, Robert H Eckel, Ira J Goldberg. Arterioscler Thromb Vasc Biol 2018
52
10


Adverse Drug Reaction Profile of SGLT2 Inhibitor-Associated Diabetic Ketosis/Ketoacidosis in Singapore and their Precipitating Factors.
Michael Limenta, Christine S C Ho, Jalene W W Poh, Su-Yen Goh, Dorothy S L Toh. Clin Drug Investig 2019
10
10


Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: the population-based registry in the province of Turin, Italy.
Graziella Bruno, Cristina Runzo, Paolo Cavallo-Perin, Franco Merletti, Marina Rivetti, Silvia Pinach, Giulia Novelli, Mariella Trovati, Franco Cerutti, Gianfranco Pagano. Diabetes Care 2005
115
10

The use of metformin in type 1 diabetes: a systematic review of efficacy.
S Vella, L Buetow, P Royle, S Livingstone, H M Colhoun, J R Petrie. Diabetologia 2010
127
10



The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin.
Matthias Kern, Nora Klöting, Michael Mark, Eric Mayoux, Thomas Klein, Matthias Blüher. Metabolism 2016
68
10

Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit.
Fernand Bteich, Ghassan Daher, Aniruddh Kapoor, Edward Charbek, Ghassan Kamel. Cureus 2019
4
25

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management.
Arun Chaudhury, Chitharanjan Duvoor, Vijaya Sena Reddy Dendi, Shashank Kraleti, Aditya Chada, Rahul Ravilla, Asween Marco, Nawal Singh Shekhawat, Maria Theresa Montales, Kevin Kuriakose,[...]. Front Endocrinol (Lausanne) 2017
376
10



Diabetes and its drivers: the largest epidemic in human history?
Paul Z Zimmet. Clin Diabetes Endocrinol 2017
122
10

Glucocorticoid-induced hyperglycemia.
John N Clore, Linda Thurby-Hay. Endocr Pract 2009
246
10

Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus.
A Goday, D Bellido, I Sajoux, A B Crujeiras, B Burguera, P P García-Luna, A Oleaga, B Moreno, F F Casanueva. Nutr Diabetes 2016
99
10

Euglycemic Diabetic Ketoacidosis Precipitated by a Keto Diet: Importance of Dietary History in Diagnosis.
Safia Shaikh, Mohamed Mg Mohamed, Abdul Mujeeb, Faizan Shaikh, Benjamin Harris. Cureus 2020
5
20

Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother. Diabetes Metab Res Rev 2017
95
10

Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis.
Emma Sainsbury, Nathalie V Kizirian, Stephanie R Partridge, Timothy Gill, Stephen Colagiuri, Alice A Gibson. Diabetes Res Clin Pract 2018
99
10

Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis.
Xiaofang Yu, Saifei Zhang, Long Zhang. Int J Endocrinol 2018
21
10

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.
Brendon L Neuen, Tamara Young, Hiddo J L Heerspink, Bruce Neal, Vlado Perkovic, Laurent Billot, Kenneth W Mahaffey, David M Charytan, David C Wheeler, Clare Arnott,[...]. Lancet Diabetes Endocrinol 2019
321
10

Guidelines and controversies in the management of diabetic ketoacidosis - A mini-review.
Tasnim Islam, Khalid Sherani, Salim Surani, Abhay Vakil. World J Diabetes 2018
6
16

Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.
Yuita Fukuyama, Kenji Numata, Kaede Yoshino, Takushi Santanda, Hiraku Funakoshi. Acute Med Surg 2020
9
11

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study.
Antonios Douros, Lisa M Lix, Michael Fralick, Sophie Dell'Aniello, Baiju R Shah, Paul E Ronksley, Éric Tremblay, Nianping Hu, Silvia Alessi-Severini, Anat Fisher,[...]. Ann Intern Med 2020
38
10

Type 1 Diabetes Mellitus and Bariatric Surgery: A Systematic Review and Meta-Analysis.
Hutan Ashrafian, Leanne Harling, Tania Toma, Christina Athanasiou, Nikolaos Nikiteas, Evangelos Efthimiou, Ara Darzi, Thanos Athanasiou. Obes Surg 2016
31
10


Weight loss, improved physical performance, cognitive function, eating behavior, and metabolic profile in a 12-week ketogenic diet in obese adults.
Nina Mohorko, Maša Černelič-Bizjak, Tamara Poklar-Vatovec, Gašper Grom, Saša Kenig, Ana Petelin, Zala Jenko-Pražnikar. Nutr Res 2019
46
10

Can a ketogenic diet be safely used to improve glycaemic control in a child with type 1 diabetes?
Anne-Marie McClean, Luca Montorio, Diarmuid McLaughlin, Shelia McGovern, Nuala Flanagan. Arch Dis Child 2019
7
14

A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes.
Laura R Saslow, Sarah Kim, Jennifer J Daubenmier, Judith T Moskowitz, Stephen D Phinney, Veronica Goldman, Elizabeth J Murphy, Rachel M Cox, Patricia Moran, Fredrick M Hecht. PLoS One 2014
93
10




Diabetic ketoacidosis occurring with lower blood glucose levels in pregnancy: a report of two cases.
Monika Madaan, Kiran Aggarwal, Ritu Sharma, Shubha Sagar Trivedi. J Reprod Med 2012
16
10

Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis.
Tadashi Toyama, Brendon L Neuen, Min Jun, Toshiaki Ohkuma, Bruce Neal, Meg J Jardine, Hiddo L Heerspink, Muh Geot Wong, Toshiharu Ninomiya, Takashi Wada,[...]. Diabetes Obes Metab 2019
112
10

Low-Carb and Ketogenic Diets in Type 1 and Type 2 Diabetes.
Andrea Mario Bolla, Amelia Caretto, Andrea Laurenzi, Marina Scavini, Lorenzo Piemonti. Nutrients 2019
57
10

Very restricted carbohydrate (ketogenic) diet: A rare cause of a recurrent hypoglycemic-euglycemic diabetic ketoacidosis in the pregnancy.
Marianna Yaron, Roi Shalit, Doron Kreiser, Tali Cukierman-Yaffe, Rakefet Yoeli. Eur J Obstet Gynecol Reprod Biol 2020
2
50

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
10

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Martina Brueckmann, Anne Pernille Ofstad, Egon Pfarr, Waheed Jamal,[...]. Lancet 2020
394
10

Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology.
Petar M Seferović, Gabriele Fragasso, Mark Petrie, Wilfried Mullens, Roberto Ferrari, Thomas Thum, Johann Bauersachs, Stefan D Anker, Robin Ray, Yuksel Çavuşoğlu,[...]. Eur J Heart Fail 2020
65
10

Prescription patterns of diabetes medications influencing clinical outcomes of heart failure patients with reduced ejection fraction.
Hung-Yu Chang, Yu-Wen Su, An-Ning Feng, Man-Cai Fong, Kuan-Chih Huang, Eric Chong, Kuan-Chun Chen, Wei-Hsian Yin. ESC Heart Fail 2020
5
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.